Open Access

Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population

  • Authors:
    • Nidia Samara Rodríguez-Rivera
    • Patricia Cuautle-Rodríguez
    • Fernando Castillo-Nájera
    • Juan Arcadio Molina-Guarneros
  • View Affiliations

  • Published online on: June 2, 2017     https://doi.org/10.3892/br.2017.921
  • Pages: 21-28
  • Copyright: © Rodríguez-Rivera et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Type 2 diabetes mellitus (T2DM) is one of the most prevalent chronic pathologies in the world. In developing countries, such as Mexico, its prevalence represents an important public health and research issue. Determining factors triggering T2DM are environmental and genetic. While diet, exercise and proper weight control are the first measures recommended to improve the quality of life and life expectancy of patients, pharmacological treatment is usually the next step. Within every population there are variations in interindividual drug response, which may be due to genetic background. Some of the most frequent first line T2DM treatments in developing countries are sulfonylureas (SU), whose targets are ATP-sensitive potassium channels (KATP). Single nucleotide polymorphisms (SNPs) of the KATP coding genes, potassium voltage-gated channel subfamily J member 11 (KCNJ11) and ATP binding cassette subfamily C member 8 (ABCC8) have been associated with SU response variability. To date, there is little information regarding the mechanism by which these SNPs work within Mexican populations. The present study describes the distribution of three SNPs [KCNJ11 rs5219 (E23K), ABCC8 rs757110 (S1369A) and rs1799854 (-3C/T)] among Mestizo Mexican (MM) T2DM patients, and compares it with published data on various healthy subjects and T2DM populations. Through this comparison, no difference in the KCNJ11 rs5219 and ABCC8 rs757110 allelic and genotypic frequencies in MM were observed compared with the majority of the reported populations of healthy and diabetic individuals among other ethnic groups; except for African and Colombian individuals. By contrast, ABCC8 rs1799854 genomic and allelic frequencies among MM were observed to be significantly different from those reported by the 1000 Genomes Project, and from diabetic patients within other populations reported in the literature, such as the European, Asian and Latin-American individuals [T=0.704, G=0.296; CC=0.506, CT=0.397, TT=0.097; 95% confidence interval (CI); P≤0.05]; except for South Asian and Iberian populations, which may reflect the admixture origins of the present Mexican population. This genetic similarity has not been observed in the other Latin-American groups. To the best of our knowledge, this is the first study of ABCC8 rs757110 and rs1799854 SNP frequencies in any Mexican population and, specifically with diabetic Mexicans. Knowledge of the genetic structure of different populations is key to understanding the interindividual responses to drugs, such as SU and whether genotypic differences affect clinical outcome.
View References

Related Articles

Journal Cover

July-2017
Volume 7 Issue 1

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Rodríguez-Rivera NS, Cuautle-Rodríguez P, Castillo-Nájera F and Molina-Guarneros JA: Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population. Biomed Rep 7: 21-28, 2017.
APA
Rodríguez-Rivera, N.S., Cuautle-Rodríguez, P., Castillo-Nájera, F., & Molina-Guarneros, J.A. (2017). Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population. Biomedical Reports, 7, 21-28. https://doi.org/10.3892/br.2017.921
MLA
Rodríguez-Rivera, N. S., Cuautle-Rodríguez, P., Castillo-Nájera, F., Molina-Guarneros, J. A."Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population". Biomedical Reports 7.1 (2017): 21-28.
Chicago
Rodríguez-Rivera, N. S., Cuautle-Rodríguez, P., Castillo-Nájera, F., Molina-Guarneros, J. A."Identification of genetic variants in pharmacogenetic genes associated with type 2 diabetes in a Mexican-Mestizo population". Biomedical Reports 7, no. 1 (2017): 21-28. https://doi.org/10.3892/br.2017.921